To determine the effects of additional nursing care in the treatment of asthma and COPD patients at a pulmonary outpatient clinic.
In a randomized, double blind clinical trial, 191 patients were allocated to an additional care (ACG) or control group (CG). Patients were masked for the trial objectives. Patients in the ACG group received an extra education program on individual basis provided by a pulmonary nurse. Between initial and final assessments was a six months interval.
97 patients were randomized to the additional care group and 94 to the control group of which 157 finished the trial. Small albeit significant differences were found for the outcomes knowledge and exacerbation rate in favour of the additional care group. No differences were found for self-management scores, inhalation technique, health-related quality of life and satisfaction with provided care.
for the outcomes knowledge and exacerbation rate patients in the additional care group had significant better results. No differences were found for the outcomes self-management scores, inhalation technique, health-related quality of life and satisfaction with provided care.
additional care by a pulmonary nurse is easy to implement, provides patient tailored care, is easy accessible and might reduce the workload of the pulmonary physician. Since we found that some aspects were effective we conclude that it is worthwhile to consider providing additional nursing care to asthma and COPD patients in a pulmonary outpatient clinic.
Geert Rootmensen, None.
Primary outcomes: knowledge, self management, inhalation technique and exacerbation frequency incidences. Differerences between additional care (ACG) and control group (CG)ACG (n=80)median#CG (n=77) median#p-valueknowledge*initial55 (33-73)55 (41-73)final64 (38-77)59 (45-70)change score5 (-5-14)0 (-5-9)0,02inhalation technique**initial78 (68-83)70 (63-80)final83 (68-90)72 (63-83)change score0 (-5-10)0 (-8-12)0,84self managementinitial36 (25-56)36 (25-48)final38 (25-63)38 (25-53)change score3 (-12-19)6 (-10-13)0,85exacerbation frequency?incidence rate‡1,463,650,40 (0,24-0,67)= exacerbation*?11%24%0,68 (0,49-0,94)